Shopping Cart
Remove All
Your shopping cart is currently empty
Lampalizumab
😃Good
Catalog No. T76814Cas No. 1278466-20-8
Alias TNX234, TNX 234, RG7417, RG 7417, Anti-CFD Recombinant Antibody
Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research.
Lampalizumab
Lampalizumab
😃Good
Catalog No. T76814Alias TNX234, TNX 234, RG7417, RG 7417, Anti-CFD Recombinant AntibodyCas No. 1278466-20-8
Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | In Stock | In Stock | |
| 5 mg | $795 | In Stock | In Stock | |
| 10 mg | $1,260 | - | In Stock | |
| 25 mg | $1,870 | - | In Stock | |
| 50 mg | $2,520 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.46% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research. |
| In vivo | Lampalizumab achieved rapid equilibrium in eye tissue after intravitreal administration in cynomophagus monkeys. Its elimination is relatively slow in the eyes, τ1/2 in about 3 days, while the whole body is quickly eliminated, τ1/2 in 0.8 hours. [1] |
| Synonyms | TNX234, TNX 234, RG7417, RG 7417, Anti-CFD Recombinant Antibody |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Complement Factor D |
| Molecular Weight | 143.8 kDa |
| Cas No. | 1278466-20-8 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Lampalizumab | purchase Lampalizumab | Lampalizumab cost | order Lampalizumab | Lampalizumab in vivo | Lampalizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.